Claim
Strong Support
quantitative
A new cholesterol pill can lower bad cholesterol by 58% without needing a shot.
47
0
Evidence from Studies
Supporting (1)
47
Community contributions welcome
47
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical Trial.
Randomized Controlled Trial
Human
1988 JunDirect test
Why it supportsThe study tested an oral pill that blocks a protein called PCSK9 and found it lowered bad cholesterol by about 58%, just like the claim says.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
Limits worth knowing
- No clinical evidence is available; the score reflects mechanistic plausibility only.
